Serum oxytocinase activity is related to tumor growth parameters in N-methyl nitrosourea induced rat breast cancer

Life Sciences

Volumn 75, Issue 11, 2004, Pages 1369-1377

  Carrera, M P ^a   Ramirez Exposito M J ^a   Valenzuela, M T ^b   Garcia M J ^a   Mayas, M D ^a   Martinez Martos J M ^a  

^a UNIVERSITY OF JAÉN   (Spain)

^b HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

Mammary gland; N methyl nitrosourea; Oxytocin; Oxytocinase; Tumor growth parameters

Indexed keywords

BIOLOGICAL MARKER; CYSTYL AMINOPEPTIDASE; METHYLNITROSOUREA; OXYTOCIN;

ANIMAL MODEL; ARTICLE; BODY WEIGHT; BREAST CANCER; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE MARKER; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; NONHUMAN; RAT; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; BODY WEIGHT; CARCINOGENS; CYSTINYL AMINOPEPTIDASE; DISEASE MODELS, ANIMAL; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; METHYLNITROSOUREA; RATS; RATS, WISTAR;

ANIMALIA;

EID: 3042691511     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2004.04.009     Document Type: Article

References (23)

1. Argiolas A., Gessa G.L. Central functions of oxytocin. Neuroscience and Behavioural Reviews. 15:1990;217-231
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry. 72:1976;248-254
3. Bussolati G., Cassoni P., Ghisolfi G., Negro F., Sapino A. Immunolocalization and gene expression of oxytocin receptor in carcinomas and non-neoplastic tissue of the breast. American Journal of Pathology. 48:1996;1895-1903
4. Carrera M.P., Ramírez-Expósito M.J., Valenzuela M.T., García M.J., Mayas M.D., Martínez-Martos J.M. Serum pyrrolidon carboxypeptidase activity in N-methyl nitrosourea induced rat breast cancer. Hormone and Metabolic Research. 35:2003;502-505
5. Cassoni P., Sapino A., Negro A.F., Bussolati G. Oxytocin inhibits proliferation of human breast cancer cell lines. Virchows Archives. 425:1994;467-472
6. Cassoni P., Marrocco T., Deaglio S., Sapino A., Bussolati G. Biological relevance of oxytocin and oxytocin receptors in cancer cells and primary tumors. Annals of Oncology. 12(Suppl 2):2001;S37-S39
7. Copland J.A., Jeng Y.J., Strakova Z., Ives K.L., Hellmich M.R., Soloff M.S. Demostration of functional oxytocin receptors in human breast Hs 578 T cells and their up-regulation through a protein kinase C-dependent pathway. Endocrinology. 140:1998;2258-2267
8. Grazzini E., Guillon G., Mouillac B., Zing H.H. Inhibition of oxytocin receptor function by direct binding of progesterone. Nature. 392:1998;509-512
9. Gullino P.M., Pettigrew H.M., Grantham F.H. N-nitrosomethylurea as mammary gland carcinogen in rats. Journal of the National Cancer Institute. 54:1975;401-414
10. Huirne J.A., Lambalk C.B. Gonadotropin-releasing-hormone-receptor antagonists. Lancet. 358:2001;1793-1803
11. Martínez J.M., Prieto I., Ramírez M.J., Cueva C., Alba F., Ramírez M. Aminopeptidase activities in breast cancer tissues. Clinical Chemistry. 10:1999;1797-1802
12. Mc Cormick D.L., Adamowski C.B., Filks A., Moon R.C. Lifetime dose-response relationship of mammary tumor induction by a single administration of-methyl-nitrosourea. Cancer Research. 41:1981;1690-1694
13. Mizutani S., Safwaz M.A., Goto K., Tsujimoto M., Nakazato H., Itakura A., Mizuno M., Kurauchi O., Kikkawa F., Tomoda Y. Initiating and responsible enzyme of arginine vasopressin degradation in human placenta and pregnancy serum. Regulatory Peptides. 59:1995;371-378
14. Murrell T.G. The potential for oxytocin to prevent breast cancer; a hypothesis. Breast Cancer Research and Treatment. 35:1995;225-229
15. Nagasaka T., Nomura S., Okamura M., Tsujimoto M., Nagazato H., Oiso Y., Nakashima N., Mizutani S. Immunohistochemical localization of placental leucine aminopeptidase / oxytocinase in normal human placental, fetal and adult tissue. Reproduction, Fertility and Development. 9:1997;1-7
16. North W.G., Pai S., Friedman A., Yu X., Fay M., Memoli V. Vasopressin gene related products are markers of human breast cancer. Breast Cancer Research and Treatment. 34:1995;229-235
17. Rivera E.S., Andrade N., Martin G., Melito G., Cricco G., Mohamed N., Davio C., Caro R., Bergoc R.M. Induction of mammary tumors in rat by intraperitoneal injection of NMU: histopathology and estral cycle influence. Cancer Letters. 86:1994;223-228
18. Russo J., Russo I.H. Atlas and histologic classification of tumors of the rat mammary gland. Journal of Mammary Gland Biology and Neoplasia. 5:2000;187-200
19. Russo J., Gusterson B.A., Rogers A.E., Russo I.H., Wellings S.R., van Zwieten M.J. Biology of disease; Comparative study of human and rat mammary tumorigenesis. Laboratory Investigation. 62:1990;244-278
20. Sapino A., Cassoni P., Stella A., Bussolati G. Oxytocin receptor within the breast: biological function and distribution. Anticancer Research. 18:1998;2181-2186
21. Thompson H.J., Adlaka H. Dose-responsive induction of mammary gland carcinomas by the intraperitoneal injection of 1-methyl-1 nitrosourea. Cancer Research. 51:1991;3412-3415
22. Tsujimoto M., Mizutani S., Adachi H., Kimura M., Nakazato H., Tomoda Y. Identification of human placental leucine aminopeptidase as oxytocinase. Archives of Biochemistry and Biophysic. 292:1992;388-392
23. Welsch C.W. Host factors affecting the growth of carcinogen induced rat mammary carcinomas: A review and tribute to Charles Breton Huggings. Cancer Research. 45:1985;3415-3443